Skip navigation

Advance Analytical Tools to Strengthen Compliance Programs and Enhance Business Intelligence

January 23-24, 2019
  • Philadelphia, PA

CBI’s 2nd Annual Data Analytics and Decisions focuses on data analytics to make strategic business decisions that will strengthen compliance monitoring and improve commercial business performance. Currently, bio/pharmaceutical and device companies are focused on streamlining their data collection practices, determining the metrics to focus on, choosing how to visualize results and analyzing best practices to filter the results. This program offers the opportunity for those with a focus on analytics, monitoring, and IT to further discuss how to integrate new technologies into the decision making of bio/pharmaceutical and device companies.

Key Insights and Takeaways:

  • Discuss the increased use of data in analyzing trends
    for fraud and the use of data to identify outliers
  • Strengthen risk management and business intelligence
    for third-party data
  • Ensure comprehensive collection and reporting of accurate physician spend data for speaker programs
  • Examine the story behind the data and how to shift
    your focus away from the results
  • Discover how to improve systems for data remediation and validation
  • Solidify an approach for cleaning internal data and analyzing external data
  • Examine the different approaches when comparing
    US and Global data sets

Data Analytics and Decisions

Advance Analytical Tools to Strengthen Compliance Programs and Enhance Business Intelligence

CBI’s 2nd Annual Data Analytics and Decisions focuses on data analytics to make strategic business decisions that will strengthen compliance monitoring and improve commercial business performance. Currently, bio/pharmaceutical and device companies are focused on streamlining their data collection practices, determining the metrics to focus on, choosing how to visualize results and analyzing best practices to filter the results. This program offers the opportunity for those with a focus on analytics, monitoring, and IT to further discuss how to integrate new technologies into the decision making of bio/pharmaceutical and device companies.

Key Insights and Takeaways:

  • Discuss the increased use of data in analyzing trends
    for fraud and the use of data to identify outliers
  • Strengthen risk management and business intelligence
    for third-party data
  • Ensure comprehensive collection and reporting of accurate physician spend data for speaker programs
  • Examine the story behind the data and how to shift
    your focus away from the results
  • Discover how to improve systems for data remediation and validation
  • Solidify an approach for cleaning internal data and analyzing external data
  • Examine the different approaches when comparing
    US and Global data sets